These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 11454517
1. Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. Seck T, Diel I, Bismar H, Ziegler R, Pfeilschifter J. Eur J Endocrinol; 2001 Aug; 145(2):199-205. PubMed ID: 11454517 [Abstract] [Full Text] [Related]
2. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B. Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766 [Abstract] [Full Text] [Related]
3. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Lee SK, Lorenzo JA. Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442 [Abstract] [Full Text] [Related]
4. PTH differentially regulates expression of RANKL and OPG. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA. J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393 [Abstract] [Full Text] [Related]
5. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Palmqvist P, Persson E, Conaway HH, Lerner UH. J Immunol; 2002 Sep 15; 169(6):3353-62. PubMed ID: 12218157 [Abstract] [Full Text] [Related]
6. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H, Guo J, Bringhurst FR. J Bone Miner Res; 2002 Sep 15; 17(9):1667-79. PubMed ID: 12211438 [Abstract] [Full Text] [Related]
7. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. J Endocrinol; 2003 Jun 15; 177(3):423-33. PubMed ID: 12773123 [Abstract] [Full Text] [Related]
8. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Lee SK, Lorenzo JA. Endocrinology; 1999 Aug 15; 140(8):3552-61. PubMed ID: 10433211 [Abstract] [Full Text] [Related]
9. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Ikeda T, Utsuyama M, Hirokawa K. J Bone Miner Res; 2001 Aug 15; 16(8):1416-25. PubMed ID: 11499864 [Abstract] [Full Text] [Related]
10. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. Cao J, Venton L, Sakata T, Halloran BP. J Bone Miner Res; 2003 Feb 15; 18(2):270-7. PubMed ID: 12568404 [Abstract] [Full Text] [Related]
11. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Nagasawa T, Kobayashi H, Kiji M, Aramaki M, Mahanonda R, Kojima T, Murakami Y, Saito M, Morotome Y, Ishikawa I. Clin Exp Immunol; 2002 Nov 15; 130(2):338-44. PubMed ID: 12390325 [Abstract] [Full Text] [Related]
12. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N, Maeda H, Yoshimine Y, Akamine A. Bone; 2004 Sep 15; 35(3):629-35. PubMed ID: 15336598 [Abstract] [Full Text] [Related]
13. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts]. Tian QX, Huang GY. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug 15; 26(4):418-22. PubMed ID: 15379268 [Abstract] [Full Text] [Related]
14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. J Bone Miner Res; 2005 Sep 15; 20(9):1659-68. PubMed ID: 16059637 [Abstract] [Full Text] [Related]
16. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75]. Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang LZ, Xu MY, Chen JL. Zhonghua Nei Ke Za Zhi; 2004 Jun 15; 43(6):447-50. PubMed ID: 15312444 [Abstract] [Full Text] [Related]
20. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. Fu Q, Jilka RL, Manolagas SC, O'Brien CA. J Biol Chem; 2002 Dec 13; 277(50):48868-75. PubMed ID: 12364326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]